Regenerative Therapies
Experience Cutting Edge Regenerative Therapies with KYZN Clinics at Total Health West Berkshire
Total Health West Berkshire is delighted to have KYZN Clinics offering their expert regenerative therapies for orthopaedics and sports injuries.
These treatments represent the pinnacle of our expertise, offering a broad range of advanced solutions for musculoskeletal issues.
With a range of non-surgical intervention together with comprehensive care is designed to address your specific needs and restore your mobility and quality of life.
Non Surgical and Injectable Treatment Options
KYZN Clinics’ Regenerative Therapies are designed to offer a full spectrum of care for musculoskeletal issues, ranging from minor injuries to complex conditions.
Our flagship service is characterised by our extensive expertise and use of advanced diagnostic and treatment techniques.
Our new generation of regenerative therapies is designed to support the body’s natural healing processes, offering a potential alternative to surgery and aiming to address underlying medical conditions.
This partnership between KYZN Clinics and Total Health West Berkshire brings cutting-edge regenerative and longevity medicine to the clinic, including:
-
Innovative treatments for orthopaedic conditions, pain management, and musculoskeletal health.
-
Exclusive regenerative procedures including ultrasound guided injectable treatment.
-
Comprehensive longevity medicine, enhancing overall health and well-being.
-
Expert-led clinical collaboration, ensuring the highest standard of care.
Why Choose KYZN Clinics?
Expert Consultation:
Detailed assessment by our highly skilled Consultant Orthopaedic Surgeon to evaluate your condition and develop a personalised treatment
Non-Surgical Treatments:
Provides a comprehensive selection of non-invasive and regenerative therapies aimed at managing pain, enhancing mobility, and supporting long-term functional improvement.
Bespoke Treatment Plans:
Tailored to your unique diagnosis, lifestyle, and personal health goals, our bespoke plans ensure a highly targeted and effective approach to your care and recovery.
Personalised Care Ongoing Support and Follow-Up:
Your journey doesn’t end after treatment. We provide dedicated follow-up and tailored support to ensure your progress is closely monitored, your care plan evolves with your needs, and you continue to achieve lasting, meaningful results.
How It Works
1) Consultation
Your journey begins with a comprehensive consultation, where we take time to understand your symptoms, medical history, and lifestyle. If appropriate, we may recommend advanced imaging such as MRI to support a precise diagnosis and help tailor the most effective treatment plan for you.
2) Personalised Treatment Plan
Following your consultation, we create a personalised care plan tailored to your specific needs and goals. This may include regenerative therapies, guided rehabilitation, or other targeted non-surgical interventions to support optimal recovery and long-term well-being.
3) Precision Treatment
Receive world-class care by a leading expert in regenerative medicine. Your personalised treatment is delivered using advanced, minimally invasive techniques designed to support faster recovery, enhance mobility, and help you feel your best with confidence and comfort.
About KYZN
KYZN is a leading British healthcare company renowned for its expertise in advanced medical treatments. Our team comprises of globally recognised experts dedicated to revolutionising healthcare.
Innovative Medical Treatments
KYZN develops advanced medical treatments using cutting-edge technology to enhance natural healing processes.
Groundbreaking Biotechnologies
We lead in biotechnology innovation, pushing healthcare boundaries with our commitment to research and development.
Commitment to Research
Continuous research keeps KYZN at the forefront of medical and technological advancements.
Vision for a Healthier Tomorrow
Our mission is to enhance natural healing and create a healthier future through continuous healthcare innovation.
Mr Ansar Mahmood (He/Him)
Consultant Orthopaedic Trauma Surgeon, MB, ChB, MRCS Ed, FRCS Tr&Orth), DABRM
Mr Mahmood is a Consultant Orthopaedic Surgeon in one of the leading Major Trauma units in the UK. Fellowship Trained in Orthopaedic Trauma Surgery, with Specialist interests including Major Orthopaedic Trauma, Sports & Tendon injuries & post trauma reconstruction. He is the University Hospital Lead for Trauma Research. Research interests include Platelet Rich Plasma (PRP) and Ortho-biologics and their use in musculoskeletal conditions and wound healing.
Mr Mahmood is a Senior Clinical Lecturer in the Institute of Inflammation & Ageing at the University of Birmingham and major trauma research lead at the Institute of Translational Medicine. He is one of the first and very few holders of the Diploma from the American Board of Regenerative Medicine awarded by the American Academy of Regenerative Medicine in the UK & Europe. He founded the UK based Academy of Regenerative Medicine which is the premier provider of education and accredited training in regenerative medicine in Europe.
He is also one of the few Orthopaedic surgeons in the UK that is trained in Ultrasound and does all of his treatments under ultrasound guidance to enable a higher level of precision and improve patient outcomes from non-surgical or minimally invasive techniques.
Currently the President of the British Trauma Society he also created the internationally recognised MISTT course which uniquely trains teams to plan and manage trauma in mass casualty situations and is accredited by the Royal College of Surgeons Ed. & recognised by the World Health Organisation. He is invited to lecture and train clinicians around the world on a regular basis.
He is passionate about the scientific endeavour behind our practice of medicine and surgery and believes big data and machine learning/AI will be instrumental to our decision making for trauma and medicine in the future. He gave a lecture on AI in Trauma at the British Orthopaedic Association conference and is involved in research with the AI research group at the University of Birmingham.